Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
about
A review of malaria vaccine clinical projects based on the WHO rainbow tableThat Was Then But This Is Now: Malaria Research in the Time of an Eradication AgendaThe role of research in viral disease eradication and elimination programs: lessons for malaria eradicationAnimal models for the study of HCVDevelopment of humanized mouse models to study human malaria parasite infectionVaccines for malaria: how close are we?Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41In vivo CD8+ T cell dynamics in the liver of Plasmodium yoelii immunized and infected miceNew horizons for studying human hepatotropic infectionsStructure of the Plasmodium 6-cysteine s48/45 domainDisruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasitesThe March Toward Malaria VaccinesRemoval of heterologous sequences from Plasmodium falciparum mutants using FLPe-recombinaseBiochemical and functional analysis of two Plasmodium falciparum blood-stage 6-cys proteins: P12 and P41A novel Pfs38 protein complex on the surface of Plasmodium falciparum blood-stage merozoitesAMA1 and MAEBL are important for Plasmodium falciparum sporozoite infection of the liverMalaria parasites target the hepatocyte receptor EphA2 for successful host infectionComplete Plasmodium falciparum liver-stage development in liver-chimeric mice.Three members of the 6-cys protein family of Plasmodium play a role in gamete fertilityThe acute transcriptomic and proteomic response of HC-04 hepatoma cells to hepatocyte growth factor and its implications for Plasmodium falciparum sporozoite invasion.Genetically modified organisms and visceral leishmaniasisMultiplex, DNase-free one-step reverse transcription PCR for Plasmodium 18S rRNA and spliced gametocyte-specific mRNAs.Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria VaccinePlasmodium P36 determines host cell receptor usage during sporozoite invasionA research agenda for malaria eradication: basic science and enabling technologiesMinimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoitesMalaria gametocytogenesis.Identification of pre-erythrocytic malaria antigens that target hepatocytes for killing in vivo and contribute to protection elicited by whole-parasite vaccination.An update on the rapid advances in malaria parasite cell biology.Protection from experimental cerebral malaria with a single dose of radiation-attenuated, blood-stage Plasmodium berghei parasites.Knockout of the dhfr-ts gene in Trypanosoma cruzi generates attenuated parasites able to confer protection against a virulent challenge.Advances and challenges in malaria vaccine development.Plasmodium berghei Δp52&p36 parasites develop independent of a parasitophorous vacuole membrane in Huh-7 liver cellsMalaria Parasite Liver Infection and Exoerythrocytic Biology.A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoitesPlasmodium Cysteine Repeat Modular Proteins 3 and 4 are essential for malaria parasite transmission from the mosquito to the host.Malaria parasite-synthesized heme is essential in the mosquito and liver stages and complements host heme in the blood stages of infectionMalaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans?Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasitesA monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.
P2860
Q21034112-971C7C76-F574-4BF0-BDBE-C1A04BC54A0EQ22061808-41CC8DC0-A32E-43A6-860B-5AC38C1EA099Q26700366-DFF91DA6-129B-42CC-99B6-FEE5B4FD4754Q26797836-451E6235-D676-4C52-A93A-D36547088181Q26851983-F06B02B6-C3A9-44CD-A41C-8C2FA11365F2Q27024344-20260602-4E82-430E-8195-FCE9CEF689D3Q27230051-90A92BAE-31C6-471C-A5AC-D681C689DF89Q27310073-E4EDBADF-1C7F-40A5-B427-FCC4875FC655Q27490975-A386D8D9-CF49-4665-B8E9-00FB4151CEECQ27678432-36BF17EF-D854-4044-82D0-F23D39761971Q27974558-96A08FB3-2C04-4BB3-BB2D-60521121CB0FQ28084325-094CC995-555F-4DDB-9268-0DA6BD995EDBQ28476396-986197FC-C91C-4B1C-975D-5AC537EDB2ADQ28481599-511831FA-F356-45EC-BBF9-C1EC4FC44BD3Q30038987-AFAED0D6-623B-4180-AC68-97D1CF447097Q30044955-AA9E23C9-3E45-4821-9925-A8003E1368D7Q30047034-A75B5519-5D61-4465-B828-BE2334CA4344Q30525395-89AC48C2-CF0B-4A42-BEB9-17EA6C030DCCQ33553363-0B2FB095-54AF-4659-9D4B-861CF343BBFCQ33583133-70A9E132-D7EF-40DB-A533-6A94E5D59346Q33647026-D4C90097-0A82-47A2-AF62-A220DA9B2D90Q33709137-C9DA2AC2-D4DC-4649-8F05-0D7F70030CF2Q33744460-81EC49DA-037C-494B-8528-9BA2FA48D251Q33798033-5201622F-D0C6-4AAA-AE95-4542A8C03C4AQ33818036-CD4540A3-C5DB-490B-97B2-AC2C4812CBC4Q33826130-6D686AE6-0C4C-4EA4-8534-D1A29E050DCBQ33894262-311BF366-12D6-4F79-B73F-7905C3DE5E83Q33905005-7EB0D803-0EFB-4D6C-A16B-3CE752303784Q33905946-A21B738C-5A3C-4F29-A5F6-3126E2E7EF3CQ34026083-5FD4F815-0FA1-4C17-B596-5E5BE8539CCDQ34105267-9D4E9917-1712-45A7-B7D5-2D75C5803419Q34145333-900EFC35-087B-46DF-A17F-8B107FD1D48BQ34507085-1B0567F0-D1AC-4D7F-B971-700F1B9C771FQ34552223-18CB103B-2CE5-499A-A3D9-E0786F3A234AQ34753532-630E2029-CFB1-438B-BD23-9B4913F04AC0Q34871838-237EDD1B-C92F-4F3F-AB0A-F36D632FE535Q34916854-AB5A1506-1359-4745-8B21-F8C2EF30FEF7Q34983659-158D69A4-A866-46FC-BEEB-F04695CDD413Q35051549-6031E566-8067-4ED5-986E-BCBD0E4FE219Q35097813-12B76B9C-C458-481D-B1AA-8675FF65780A
P2860
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
@ast
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
@en
type
label
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
@ast
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
@en
prefLabel
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
@ast
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
@en
P2093
P2860
P50
P921
P3181
P356
P1476
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design
@en
P2093
Ahmed S I Aly
Brant A Murdock
Donald G Heppner
Jack Williams
John B Sacci
Kelley M VanBuskirk
Matthew T O'Neill
Megan G Dowler
Niwat Kangwanrangsan
Norman M Kneteman
P2860
P304
P3181
P356
10.1073/PNAS.0906387106
P407
P577
2009-08-04T00:00:00Z